Skip to main content
. 2000 May;172(5):305–308. doi: 10.1136/ewjm.172.5.305

Table 3.

Financial analysis of the mass medication program for enterobiasis*

Year, Enterobius vermicularis prevalence, estimated cases (No.)/1,000 residents Cost of treatment = No. of cases treated × cost ($8) per resident, $ Cost of contact screening = No. of contacts (3/case) × cost ($5) per screening test, $ Total annual program cost for treatment and screening, $
1993, 29%, 290 2,320 4,350 6,670
1994, 21%, 210 1,680 3,150 4,830
1995, 680 5,440 0 5,440
1998, 1%, 10 2,400 0 2,400
Year, hypothetic; zero prevalence 0 0 0
*

For assumptions, see the description of the financial analysis under “Participants and methods”

Gives the actual initial cost of mass treatment of all ambulatory residents.

Includes 290 contacts.